The U.S. Food and Drugs Administration has approved Remdesivir antiviral from the pharmaceutical company Gilead as a treatment to treat Covid. This is what the Cnbc reports, recalling that in May the FDA had granted the drug an authorization for emergency use, allowing hospitals and doctors to use it on patients even without formal approval from the agency. The intravenous drug becomes the first treatment
antiviral officially approved in the United States. It will be used for infected patients forced to be hospitalized.
–
– .
Related posts:
Jack Bogle's Insights on Index Funds and the Need for Diversification in Today's Market
New Record for Tokyo Stock Exchange as Hong Kong and Chinese Markets Start Mixed
SPRC stops dividends after the poisoning of "COVID-19" presses the results of the year 63 with a los...
Corona briefing week 26: Numbers and assessments of infection rates and vaccinations